AuthorCitation

Differential Impact on Survival in Myeloid Neoplasm Patients with U2AF1 Mutations

Vanegas, Yenny Moreno , Nanaa, Ahmad , Al‐Kali, Aref , He, Rong , Patnaik, Mrinal M. , Gangat, Naseema , Litzow, Mark R. , Tefferi, Ayalew , Alkhateeb, Hassan B. , Shah, Meera , Badar, Talha

Mayo Clinic

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 9602-9603

10.1182/blood-2022-167405

TP53 Mutation Status Defines a Distinct Clinicopathological Entity of Therapy-Related Myeloid Neoplasm, Characterized By Genomic Instability and Extremely Poor Outcome

Sharplin, Kirsty, Chhetri, Rakchha , Ladon, Dariusz, Al‐Kali, Aref , Litzow, Mark R. , Mangaonkar, Abhishek A. , Gangat, Naseema , Patnaik, Mrinal M. , Begna, Kebede, Tefferi, Ayalew , Shah, Meera , Hahn, Christopher N , Tran, Elizabeth Ngoc Hoa , Baranwal, Anmol , Kutyna, Monika , Wang, Paul Po-Shen , Alkhateeb, Hassan B. , Ross, David M , Yeung, David , Shanmuganathan, Naranie , Hogan, William J. , Kumar, Sharad , Singhal, Deepak , Brown, Anna , Scott, Hamish S. , THOMAS, DANIEL W. , Kok, Chung Hoow , Hiwase, Devendra

Mayo Clinic

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 9798-9799

10.1182/blood-2022-165859

Characteristics and Outcomes of Radiation Therapy-Related Myeloid Neoplasms

Shultz, Carl , Al‐Kali, Aref , Chhetri, Rakchha , Arsana, Arini, Stish, Bradley J. , Tefferi, Ayalew , Patnaik, Mrinal M. , Gangat, Naseema , Baranwal, Anmol , Tran, Elizabeth Ngoc Hoa , Alkhateeb, Hassan B. , Hiwase, Devendra , Shah, Meera

Mayo Clinic

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 6309-6311

10.1182/blood-2022-164769

Venetoclax Plus Hypomethylating Agent (HMA) Based Induction for Treatment-Naive Older/Unfit Patients with FLT3-Mutated Acute Myeloid Leukemia (AML)

Ghorab, Ahmad , Litzow, Mark R. , Gangat, Naseema , Al‐Kali, Aref , Tefferi, Ayalew , Begna, Kebede H. , Patnaik, Mrinal M. , Foran, James M. , Ghorab, Ahmad , Shah, Meera , Murthy, Hemant S. , Alkhateeb, Hassan B. , Badar, Talha

Mayo Clinic

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 9019-9020

10.1182/blood-2022-168303

Outcome of Patients with Acute Myeloid Leukemia Following Failure of Front-Line Venetoclax Plus Hypomethylating Agent Therapy

Ilyas, Rimal, Johnson, Isla McKerrow , Al‐Kali, Aref , Begna, Kebede, Mangaonkar, Abhishek A. , Litzow, Mark R. , Patnaik, Mrinal M. , Pardanani, Animesh , Tefferi, Ayalew, Gangat, Naseema , McCullough, Kristen , Alkhateeb, Hassan B. , Hogan, William J. , Shah, Meera , Tefferi, Ayalew

Mayo Clinic

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 1286-1287

10.1182/blood-2022-165491

Response Rates to Venetoclax Based Therapies in Chronic Phase and Blast Transformed Chronic Myelomonocytic Leukemia

Litzow, Mark R. , Gangat, Naseema , Al‐Kali, Aref , Foran, James M. , Palmer, Jeanne , Mangaonkar, Abhishek A. , McCullough, Kirsten, Tefferi, Ayalew , Patnaik, Mrinal M. , Csizmar, Clifford M. , Saliba, Antoine N. , Hogan, William J. , McCullough, Kirsten, Alkhateeb, Hassan B.

Mayo Clinic

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 12238-12240

10.1182/blood-2022-165470

Leukemic Transformation of Myeloproliferative Neoplasms in the Post-Ruxolitinib Era: Analysis of 103 Consecutive Cases Diagnosed 2011-2021

Abdelmagid, Maymona, Al‐Kali, Aref , Begna, Kebede H. , Litzow, Mark R. , Mangaonkar, Abhishek A. , Patnaik, Mrinal M. , Elliott, Michelle A. , Howard, Matthew O. , Reichard, Kaaren K. , Pardanani, Animesh , Gangat, Naseema , Tefferi, Ayalew , Hogan, William J. , Alkhateeb, Hassan B. , Shi, Min , Howard, Matthew, Ketterling, Rhett P.

Mayo Clinic

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 9735-9736

10.1182/blood-2022-163450

Personalized Prediction Model to Risk Stratify Patients with Therapy-Related Myeloid Neoplasms

Ladon, Dariusz, Chhetri, Rakchha , Sharplin, Kirsty, Al‐Kali, Aref , Gangat, Naseema , Litzow, Mark R. , Kebede, Ashanka Begna, Mangaonkar, Abhishek A. , Patnaik, Mrinal M. , Tefferi, Ayalew , Kok, Chung Hoow , Tran, Elizabeth Ngoc Hoa , Baranwal, Anmol , Alkhateeb, Hassan B. , Singhal, Deepak , Yeung, David , Ross, David M , Hogan, William J. , Shanmuganathan, Naranie , Kumar, Sharad , THOMAS, DANIEL W. , Shah, Meera , Hiwase, Devendra

Mayo Clinic

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 6962-6963

10.1182/blood-2022-167978

Integrated Personalized Prediction Model Identifies a Subgroup of Wild-Type TP53therapy-Related Myeloid Neoplasm Patients with Poor Outcome

Chhetri, Rakchha , Al‐Kali, Aref , Gangat, Naseema , Litzow, Mark R. , Begna, Kebede, Mangaonkar, Abhishek A. , Patnaik, Mrinal M. , Tefferi, Ayalew , Shah, Meera , Hahn, Christopher N , Tran, Elizabeth Ngoc Hoa , Singhal, Deepak , Hogan, William J. , Kutyna, Monika , Alkhateeb, Hassan B. , Baranwal, Anmol , Shanmuganathan, Naranie , Kumar, Sharad , THOMAS, DANIEL W. , Kok, Chung Hoow , Hiwase, Devendra

Mayo Clinic

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 6964-6965

10.1182/blood-2022-168349

CPX-351 for Blast-Phase Myeloproliferative Neoplasm (MPN-BP): Mayo Clinic Experience in 10 Consecutive Patients

Ilyas, Rimal, Patnaik, Mrinal M. , Mangaonkar, Abhishek A. , Pardanani, Animesh , Tefferi, Ayalew , Gangat, Naseema , McCullough, Kristen , Badar, Talha , Alkhateeb, Hassan B.

Mayo Clinic

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 9704-9705

10.1182/blood-2022-160222

Citations

Differential Impact on Survival in Myeloid Neoplasm Patients with U2AF1 Mutations

Vanegas, Yenny Moreno , Nanaa, Ahmad , Al‐Kali, Aref , He, Rong , Patnaik, Mrinal M. , Gangat, Naseema , Litzow, Mark R. , Tefferi, Ayalew , Alkhateeb, Hassan B. , Shah, Meera , Badar, Talha

TP53 Mutation Status Defines a Distinct Clinicopathological Entity of Therapy-Related Myeloid Neoplasm, Characterized By Genomic Instability and Extremely Poor Outcome

Characteristics and Outcomes of Radiation Therapy-Related Myeloid Neoplasms

Shultz, Carl , Al‐Kali, Aref , Chhetri, Rakchha , Arsana, Arini, Stish, Bradley J. , Tefferi, Ayalew , Patnaik, Mrinal M. , Gangat, Naseema , Baranwal, Anmol , Tran, Elizabeth Ngoc Hoa , Alkhateeb, Hassan B. , Hiwase, Devendra , Shah, Meera

Venetoclax Plus Hypomethylating Agent (HMA) Based Induction for Treatment-Naive Older/Unfit Patients with FLT3-Mutated Acute Myeloid Leukemia (AML)

Ghorab, Ahmad , Litzow, Mark R. , Gangat, Naseema , Al‐Kali, Aref , Tefferi, Ayalew , Begna, Kebede H. , Patnaik, Mrinal M. , Foran, James M. , Ghorab, Ahmad , Shah, Meera , Murthy, Hemant S. , Alkhateeb, Hassan B. , Badar, Talha

Outcome of Patients with Acute Myeloid Leukemia Following Failure of Front-Line Venetoclax Plus Hypomethylating Agent Therapy

Ilyas, Rimal, Johnson, Isla McKerrow , Al‐Kali, Aref , Begna, Kebede, Mangaonkar, Abhishek A. , Litzow, Mark R. , Patnaik, Mrinal M. , Pardanani, Animesh , Tefferi, Ayalew, Gangat, Naseema , McCullough, Kristen , Alkhateeb, Hassan B. , Hogan, William J. , Shah, Meera , Tefferi, Ayalew

Response Rates to Venetoclax Based Therapies in Chronic Phase and Blast Transformed Chronic Myelomonocytic Leukemia

Litzow, Mark R. , Gangat, Naseema , Al‐Kali, Aref , Foran, James M. , Palmer, Jeanne , Mangaonkar, Abhishek A. , McCullough, Kirsten, Tefferi, Ayalew , Patnaik, Mrinal M. , Csizmar, Clifford M. , Saliba, Antoine N. , Hogan, William J. , McCullough, Kirsten, Alkhateeb, Hassan B.

Leukemic Transformation of Myeloproliferative Neoplasms in the Post-Ruxolitinib Era: Analysis of 103 Consecutive Cases Diagnosed 2011-2021

Personalized Prediction Model to Risk Stratify Patients with Therapy-Related Myeloid Neoplasms

Integrated Personalized Prediction Model Identifies a Subgroup of Wild-Type TP53therapy-Related Myeloid Neoplasm Patients with Poor Outcome

CPX-351 for Blast-Phase Myeloproliferative Neoplasm (MPN-BP): Mayo Clinic Experience in 10 Consecutive Patients

Ilyas, Rimal, Patnaik, Mrinal M. , Mangaonkar, Abhishek A. , Pardanani, Animesh , Tefferi, Ayalew , Gangat, Naseema , McCullough, Kristen , Badar, Talha , Alkhateeb, Hassan B.